Central Asset Investments & Management Holdings (Hk) LTD Regeneron Pharmaceuticals, Inc. Transaction History

Central Asset Investments & Management Holdings (Hk) LTD

$141 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $217,392 - $268,388	-400 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $229,612 - $272,384	400 New	400 $242,000

Others Institutions Holding REGN

# of Institutions

1,482

Shares Held

85.5M

Call Options Held

908K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$8.34 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$7.83 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$7.68 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$4.49 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.3 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $99.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Asset Investments & Management Holdings (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Central Asset Investments & Management Holdings (Hk) LTD with notifications on news.

Account